imovax polio injektioneste, suspensio
sanofi pasteur europe - poliovirus type 1 (mahoney), inactivated, poliovirus type 2 (mef-1), inactivated, poliovirus type 3 (saukett), inactivated - injektioneste, suspensio - inaktivoitu poliorokote
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologisia valmisteita varten felidae, - kissat - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologisia valmisteita varten felidae, - kissat - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax felv
boehringer ingelheim vetmedica gmbh - leukemiavirusta rekombinantti canarypox-virus (vcp97) - immunologisia valmisteita varten felidae, - kissat - aktiivinen immunisaatio 8 viikon ikäisten tai vanhempien kissojen leukemiaa vastaan jatkuvan viraemian ja siihen liittyvän taudin kliinisten oireiden ehkäisemiseksi. immuniteetin puhkeaminen on osoitettu 2 viikon kuluttua perusrokotuskurssista. immuniteetin kesto on yksi vuosi viimeisestä rokotuksesta.
porcilis parvo vet. injektioneste, suspensio
intervet international b.v. - sian parvovirus inaktivoitu, kanta 014 - injektioneste, suspensio - sian parvovirus -rokote
canigen dhppi/l kuiva-aine, kylmäkuivattu, ja suspensio, injektionestettä varten, suspensio
virbac - canine distemper virus, lederle strain, freeze-dried, leptospira interrogans serovar canicola, inactivated, canine parainfluenza, manhattan strain, freeze-dried, leptospira interrogans serovar icterohaemorrhagiae, inactivated, canine adenovirus, type 2, manhattan strain, freeze-dried, canine parvovirus, 780916 strain, freeze-dried - kuiva-aine, kylmäkuivattu, ja suspensio, injektionestettä varten, suspensio - koiran penikkatauti- + tarttuvamaksatulehdus- + parainfluenssa- + parvovirusrokote
bovilis rotavec corona vet. injektioneste, emulsio
intervet international b.v. - bovine rotavirus, strain uk-compton, serotype g6p5 (inactivated), bovine coronavirus, strain mebus (inactivated), escherichia coli f5 (k99) adhesin - injektioneste, emulsio
veropol injektioneste, liuos, esitäytetty ruisku
aj vaccines a/s - poliovirus type 2 (mef-1), inactivated, poliovirus type 3 (saukett), inactivated, poliovirus type 1 (brunhilde), inactivated - injektioneste, liuos, esitäytetty ruisku - inaktivoitu poliorokote
encepur 1,5 mikrog / 0,5 ml injektioneste, suspensio
bavarian nordic a/s - tick-borne encephalitis-virus (k23), kokovirus, inaktivoitu - injektioneste, suspensio - 1,5 mikrog / 0,5 ml - inaktivoitu puutiaisaivotulehdusrokote (koko virus)
hyobac app multi vet. injektioneste, emulsio
salfarm danmark a/s - actinobacillus pleuropneumoniae, serotype 6, strain wslb 3075, actinobacillus pleuropneumoniae ii toxoid, actinobacillus pleuropneumoniae i toxoid, actinobacillus pleuropneumoniae iii toxoid, actinobacillus pleuropneumoniae, serotype 5, strain wslb 3079, actinobacillus pleuropneumoniae, serotype 2, strain wslb 3012 - injektioneste, emulsio - actinobacillus/haemophilus rokote